Reply to F. Muntoni et al.: "In response to P.R. Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy
- Resource Type
- Letter
- Source
- Journal of Neuromuscular Diseases; 2023, Vol. 10 Issue 6, p1155-1157, 3p
- Subject
- Language
- ISSN
- 22143599